At the Life Sciences Commercial Contracts & Chargebacks virtual conference in June 2021, a panel of industry experts discussed how blockchain could revolutionize and automate transactions.
They explored how it could be used to collaborate with trading partners more efficiently with real-time data for more accurate pricing and reporting, as well as enforce cross-industry business rules and contracts without ever revealing your valuable, private data.
The panel featured:
- Susan Lowe, Senior Vice President, Supply Chain Operations, FFF Enterprises
- Susanne Somerville, Chief Executive Officer, Chronicled
- Laura Faddah, Project Manager, G2N CoE, Global Business Solutions, Pfizer